Cardiomyopathy is disease in which the heart muscle becomes weakened, stretched, or has another structural problem. It often contributes to the heart's inability to pump or function well.
Many people with cardiomyopathy have heart failure.
There are many types of cardiomyopathy, with different causes. Some of the more common ones are:
When possible, the cause of cardiomyopathy is treated. Medicines and lifestyle changes are often needed to treat the symptoms of heart failure, angina and abnormal heart rhythms.
Procedures or surgeries may also be used, including:
Partially and fully implantable mechanical heart pumps have been developed. These may be used for very severe cases. However, not all people need this advanced treatment.
Daniel Judge is a Cardiologist and a Heart Failure expert in Charleston, South Carolina. Judge has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Cardiomyopathy. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. He is licensed to treat patients in Maryland and South Carolina. Judge is currently accepting new patients.
Mark Sherrid is a Cardiologist in New York, New York. Sherrid has been practicing medicine for over 50 years and is rated as an Elite expert by MediFind in the treatment of Cardiomyopathy. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Subvalvular Aortic Stenosis, and Pacemaker Implantation. He is licensed to treat patients in New York. Sherrid is currently accepting new patients.
Sharlene Day is a Cardiologist in Philadelphia, Pennsylvania. Day has been practicing medicine for over 28 years and is rated as an Elite expert by MediFind in the treatment of Cardiomyopathy. She is also highly rated in 11 other conditions, according to our data. Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Cardiomyopathy, Heart Transplant, and Orchiectomy. She is licensed to treat patients in Michigan and Pennsylvania. Day is currently accepting new patients.
The outlook depends on many different things, including:
Heart failure is most often a long-term (chronic) illness. It may get worse over time. Some people develop severe heart failure. In this case, medicines, surgery, and other treatments may no longer help.
People with certain types of cardiomyopathy are at risk for dangerous heart rhythm problems.
Summary: This study will be comprised of 2 parts: Part 1 (dose escalation) will be conducted to evaluate the safety and tolerability of 2 doses (100 milligrams/kilogram [mg/kg] and 200 mg/kg) of eteplirsen in approximately 10 participants with DMD; Part 2 (dose finding and dose comparison) will be conducted for the selection of a high dose (100 mg/kg versus 200 mg/kg) and its comparison with the 30 mg/kg d...
Summary: The purpose of this study is to evaluate the efficacy and safety of patisiran in participants with ATTR amyloidosis with cardiomyopathy.
Published Date: May 08, 2022
Published By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Hershberger RE. The dilated, restrictive, and infiltrative cardiomyopathies. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 52.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421. PMID: 35379503 pubmed.ncbi.nlm.nih.gov/35379503/.
McKenna WJ, Elliott PM. Diseases of the myocardium and endocardium. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 54.
McMurray JJV, Pfeffer MA. Heart failure: management and prognosis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 53.
Rogers JG, O'Connor CM. Heart failure: pathophysiology and diagnosis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 52.